In the last few years several clinical and epidemiological studies have convincingly associated nonalcoholic fatty liver with the metabolic syndrome, having insulin resistance as the pivotal pathogenic factor. Obesity, type 2 diabetes mellitus, dyslipidemia and hypertension differently contribute to an increased risk of liver disease, and to disease progression. The presence of multiple metabolic abnormalities is associated with the severity of liver disease, namely with the fibrosis characterizing nonalcoholic steatohepatitis, with cryptogenic cirrhosis and finally with hepatocellular carcinoma. These subjects have a high risk of cardiovascular morbidity and mortality, mediated by early atherosclerosis. This evidence has precise therapeutic implications: only a behavior approach to lifestyle correction will simultaneously address all the alterations characterizing the metabolic syndrome, including metabolic liver disease.

Metabolic Syndrome and NASH / G. Marchesini Reggiani; R. Marzocchi. - In: CLINICS IN LIVER DISEASE. - ISSN 1089-3261. - STAMPA. - 11:(2007), pp. 105-117. [10.1016/j.cld.2007.02.013]

Metabolic Syndrome and NASH

MARCHESINI REGGIANI, GIULIO;MARZOCCHI, REBECCA
2007

Abstract

In the last few years several clinical and epidemiological studies have convincingly associated nonalcoholic fatty liver with the metabolic syndrome, having insulin resistance as the pivotal pathogenic factor. Obesity, type 2 diabetes mellitus, dyslipidemia and hypertension differently contribute to an increased risk of liver disease, and to disease progression. The presence of multiple metabolic abnormalities is associated with the severity of liver disease, namely with the fibrosis characterizing nonalcoholic steatohepatitis, with cryptogenic cirrhosis and finally with hepatocellular carcinoma. These subjects have a high risk of cardiovascular morbidity and mortality, mediated by early atherosclerosis. This evidence has precise therapeutic implications: only a behavior approach to lifestyle correction will simultaneously address all the alterations characterizing the metabolic syndrome, including metabolic liver disease.
2007
Metabolic Syndrome and NASH / G. Marchesini Reggiani; R. Marzocchi. - In: CLINICS IN LIVER DISEASE. - ISSN 1089-3261. - STAMPA. - 11:(2007), pp. 105-117. [10.1016/j.cld.2007.02.013]
G. Marchesini Reggiani; R. Marzocchi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/52771
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 123
  • ???jsp.display-item.citation.isi??? ND
social impact